Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRNorth America Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales) - Industry Trends and Forecast to 2030.
North America Flow Cytometry Market Analysis and Insights
North America flow cytometry market is driven by the factors such as the increasing prevalence of chronic diseases, growing demand for new technologies in the flow cytometry market, which enhances its demand, as well as increasing investment in research and development, which leads to market growth. Currently, healthcare expenditure has increased across developed and emerging countries which is expected to create a competitive advantage for manufacturers to develop new and innovative flow cytometry markets. However, the high cost of flow cytometry instruments is anticipated to restrain the growth of the North America flow cytometry market.
North America flow cytometry market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief, and our team will help you create a revenue impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for the safe distribution of machine and drug products are the major drivers which propelled the demand of the market in the forecast period.
North America flow cytometry market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.6% in the forecast period of 2023 to 2030 and is expected to reach USD 6,984.82 Million by 2030 from USD 2,725.01 Million in 2022.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales) |
|
Countries Covered |
U.S., Canada, and Mexico |
|
Market Players Covered |
Thermo Fisher Scientific Inc. (U.S.), BD(U.S.), Agilent Technologies, Inc. (U.S.), Nexcelom Bioscience LLC (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation(Japan), Miltenyi Biotec (Germany), Coherent Corp. (U.S.), Beckman Coulter, Inc. (A subsidiary of Danaher Corporation) (U.S.), Cytek Biosciences (U.S.), BIOMÉRIEUX (France), Q2 Solutions (a Subsidiary of IQVIA) (U.S.), Cytonome/ST, LLC (U.S.), Merck KGaA (Germany), Sony Biotechnology Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), NanoCellect Biomedical (U.S.), Apogee Flow Systems Ltd. (U.K.), Bay bioscience Co., Ltd. (Japan), Stratedigm, Inc., BioLegend, Inc. (U.S.), NeoGenomics Laboratories(U.S.), Enzo Biochem Inc. (U.S.), Union Biometrica, Inc. (U.S.), BennuBio Inc. (U.S.), ORLFO Technologies(U.S.), Elabscience Biotechnology Inc. (U.S.), Takara Bio Inc. (Japan), among others |
Market Definition
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.
The increasing innovations and technologies and rising number of players in the market, and novel product launches are also propelling the growth of the North America flow cytometry market.
North America Flow Cytometry Market Dynamics
Drivers
-
Rising prevalence of chronic diseases
These increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The increasing incidences of diseases lead to an increase in the North America market as many companies are investing in research and development. This resulted in the enormous lead in demand for advancements to diagnose the disease through quick and accurate techniques.
For instance,
-
In January 2021, according to a World Health Organization report, cancer became the major cause of death in 2020, with 10 million in approximation, where often cases were of breast cancer (2.26 million), lung (2.21 million), colon and rectum (1.93 million); prostate (1.41 million), skin (1.20 million) and stomach (1.09 million)
Therefore, this is raising the demand for North America flow cytometry market.
-
Increasing application of cytometry instruments
Technological developments in cytometry instruments are rising by combining several new techniques to provide high resolution and sensitivity to quantify new entities of cells.
The immunophenotypic analysis is important not only for the initial diagnosis and categorization of acute leukemia, chronic lymphoproliferative disorders, and malignant lymphomas but also for their treatment. Flow cytometry can be used as a sensitive assay to track patients' improvement after chemotherapy or transplantation and detect minimal residual illness (MRD).
For instance,
- In March 2021, Beckman Coulter introduced a CytoFLEX platform that can easily provide multicolor applications, resulting in broadening the technology's laser and color options and causing more technical advancements in this field. The company combined many technologies in CytoFLEX to produce high resolution and sensitivity
- In January 2022, Becton, Dickinson and Company, a North America medical technology company, announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published the new BD innovation in flow cytometry that adds fluorescence imaging and image-based deaccessioning to sort individual cells at exceptionally high speed, based on the visual details of each cell rather than the type or quantity of biomarkers present. The novel method has the potential to revolutionize immunology, cell biology, and genomics research, as well as enable the development of new cell-based therapeutics
Thus, this is expected to act as a driver for the growth of the North America flow cytometry market.
Opportunities
- Increase in adoption of flow cytometry techniques in research and academia
Approval of new technologies provides a new set-off venture in the market. A new mechanism of action is needed to drive the market as it provides innovation in the process by targeting with a different mechanism. It leads to the need for a new product launch in the market.
For instance,
- In March 2021, Beckman Coulter introduced a CytoFLEX platform that can easily provide multicolor applications, resulting in broadening the technology's laser and color options and causing more technical advancements in this field. The company combined many technologies in CytoFLEX to produce high resolution and sensitivity
Hence, flow cytometry provides quick and accurate techniques for diagnosing diseases. The growing demand for advanced diagnostic results for clinical purposes may propel the market's rapid growth.
- Rising healthcare expenditure
The expense of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization of the health system. In particular, there is a strong association between the complete income level of a country and how much the population of that country spends on health care.
Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the North America flow cytometry market in the forecast period of 2023-2030.
Restraints/Challenges
- High cost of flow cytometry instruments
Flow cytometers come in a variety of shapes and sizes, although benchtop instruments are the most common. They offer optimal data analysis, the convenience of use, and upgrades and options for various systems, all of which are intended to solve customized separations, cell/particle sorting, exploratory cell analysis, and other issues. All flow cytometers feature three common components – fluids, optics, and electronics/informatics.
Flow cytometers are very expensive especially considering the cost associated with repair and maintenance.
COVID-19 Impact on the North America Flow Cytometry Market
COVID-19 has positively affected the market due to disease diagnosis and research purposes, which raises the demand for flow cytometry during this period.
Recent Development
- In January 2022, Sony Biotechnology, Inc. presented a novel closed cell isolation system CGX10 for use in GMP-compliant cell sorting applications. With the initiative, new growth opportunities were hoped for the company. Such advances in technology will lead to cost-effectiveness, greater accuracy and portability and are likely to create future growth opportunities.
North America Flow Cytometry Market Scope
The North America flow cytometry market is segmented into product, technology, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product
- Reagents and consumables
- Flow cytometry instruments
- Accessories
- Services
- Software
On the basis of product, the North America flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services.
Technology
- Cell-based flow cytometry
- Bead-based flow cytometry
On the basis of technology, the North America flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.
Application
- Research applications
- Clinical applications
- Industrial applications
On the basis of application, the North America flow cytometry market is segmented into research applications, clinical applications, and industrial applications.
End User
- Pharmaceuticals & biotechnology companies
- Academic & Research institutes
- Hospitals
- Clinical testing laboratories
- Blood bank
- Others
On the basis of end users, the North America flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others.
Distribution Channel
- Retail sales
- Direct tenders
On the basis of distribution channel, the North America flow cytometry market is segmented into retail sales and direct tenders.
North America Flow Cytometry Market Regional Analysis/Insights
The North America flow cytometry market is analyzed, and market size insights and trends are provided by country, product, technology, application, end user, and distribution channel referenced above.
The U.S. is the major dominating country in the market due to the surging incidence rate of diseases such as cancer and HIV amongst the population in this country, which is boosting the demand for flow cytometry for diagnostic applications. And they are dominating the flow cytometry market in terms of market share and market revenue and will continue to flourish dominance during the forecast period.
The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of North America brands and the challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Flow Cytometry Market Share Analysis
The North America flow cytometry market competitive landscape provides details about the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the company's focus on the flow cytometry market.
Some of the major players operating in the flow cytometry market are Thermo Fisher Scientific Inc., BD, Agilent Technologies, Inc., Nexcelom Bioscience LLC, Bio-Rad Laboratories, Inc., Sysmex Corporation, Miltenyi Biotec, Coherent Corp., Beckman Coulter, Inc. (A subsidiary of Danaher Corporation), Cytek Biosciences, bioMérieux SA, Q2 Solutions (a Subsidiary of IQVIA), Cytonome/ST, LLC, Merck KGaA, Sony Biotechnology Inc., Cell Signaling Technology, Inc., NanoCellect Biomedical, Apogee Flow Systems Ltd., Bay bioscience Co., Ltd., Stratedigm, Inc., BioLegend, Inc., NeoGenomics Laboratories, Enzo Biochem Inc., Union Biometrica, Inc., BennuBio Inc., ORLFO Technologies, Elabscience Biotechnology Inc., Takara Bio Inc., among others.
SKU-
